Prognostic value of tumor disappearance rate on computed tomography in advanced-stage lung adenocarcinoma

Clinical Lung Cancer

Volumn 8, Issue 5, 2007, Pages 327-330

  Haraguchi, Norihiro ^a   Satoh, Hiroaki ^a   Kikuchi, Norihiro ^a   Kagohashi, Katsunori ^a   Ishikawa, Hiroichi ^a   Ohtsuka, Morio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Metastasis; Prognostic factor

Indexed keywords

ADULT; ADVANCED CANCER; AGED; CANCER GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; TUMOR REGRESSION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 34248163352     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2007.n.012     Document Type: Article

References (26)

1. Kuriyama K, Seto M, Kasugai T, et al. Ground-glass opacity on thin-sectiqn CT: value in differentiating subtypes of adenocarcinoma of the lung. Am J Roentgenol 1999; 173:465-469.
2. Lee KS, Kim Y, Han J. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographia 1997; 17:1345-1357.
3. Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs. Recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200:327-331.
4. Okada M, Nishio W, Sakamoto T, et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg 2004; 127:857-861.
5. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004; 28:17-23.
6. Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected sub-centimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003; 76:1016-1022.
7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717.
8. Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1N0M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002; 124:278-284.
9. Matsuguma H, Nakahara R, Anraku M, et al. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung. Eur J Cardiothorac Surg 2004; 25:1102-1106.
10. Ohde Y, Nagai K, Yoshida J, et al. The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma. Lung Cancer 2003; 42:303-310.
11. Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001; 33:17-25.
12. Takashima S, Maruyama Y, Hasegawa M, et al. Prognostic significance of high-resolution CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients. Lung Cancer 2002; 36:289-295.
13. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001; 220:803-809.
14. Dong B, Sato M, Sagawa M, et al. Computed tomographic image comparison between mediastinal and lung windows provides possible prognostic information in patients with small peripheral lung adenocarcinoma. J Thorac Cardiovasc Surg 2002; 124:1014-1020.
15. Suzuki K, Yokose T, Yoshida J, et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000; 69:893-897.
16. Goldstein NS, Mani A, Chmielewski G, et al. Prognostic factors in T1N0M0 adenocarcinomas and bronchioalveolar carcinomas of the lung. Am J Clin Pathol 1999; 112:391-402.
17. Collins J, Stern EJ. Ground-glass opacity at CT; the ABCs. Am J Roentogenol 1997; 169:355-367.
18. Sone S, Sakai F, Takashima S, et al. Factors affecting the radiologic appearance of peripheral bronchogenic carcinomas. J Thoracic Imaging 1997; 12:159-172.
19. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995; 75:2844-2852.
20. Raz DJ, He B, Rosell R, et al. Bronchioloalveolar carcinoma: a review. Clin Lung Cancer 2006; 7:313-322.
21. West H. Emerging approaches to advanced bronchioloalveolar carcinoma. Curr Treat Options Oncol 2006; 7:69-76.
22. Travis WD, Colby TV, Corrn B, et al. Histological Typing of Lung and Pleural Tumors. 3rd ed. Berlin: Springer Verlag; 1999.
23. Scagliotti G, Smit E, Bosquee L, et al. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). Lung Cancer 2005; 50:91-96.
24. Castro CY, Coffey DM, Medeiros LJ, et al. Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung. Ann Diagn Pathol 2001; 5:274-284.
25. Miller VA, Hirsch FR, Johnson DH. Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities. J Clin Oncol 2005; 23:3288-3293.
26. West HL, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126. J Clin Oncol 2006; 24:1807-1813.